Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease

3 Feb 2016

Abstract excerpt

Abstract Residual disease after neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is related with poor prognosis; however, the risk of recurrence after 3 years from surgery, becomes similar to other breast cancer subtypes indicating that TNBC is composed of tumours of different prognosis. To evaluate genes related to TNBC aggressiveness in the outcome of TNBC resistant to NAC, we profiled 82...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Cancer-related Molecular Pathways
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29263808
DOI: 10.1038/npjgenmed.2015.15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual diseasePMID 29263808Read ↗

The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity Read ↗

Transcriptome Analysis Derives a Novel Prognostic 7-mRNA Signature in Early-Stage Triple-Negative Breast CancerSemantic proximity Read ↗

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read ↗

Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysisSemantic proximity Read ↗

Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancerSemantic proximity Read ↗

A CTL/M2 Macrophage-Related Four-Gene Signature Predicting Metastasis-Free Survival in Triple-Negative Breast Cancer Treated with Adjuvant RadiotherapySemantic proximity Read ↗

TP53 signature score predicts prognosis and immune response in triple-negative breast cancerSemantic proximity Read ↗

Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSemantic proximity Read ↗

A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast CancerSemantic proximity Read ↗

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on BioinformaticsSemantic proximity Read ↗

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast CancerSemantic proximity Read ↗

Deciphering the recurrence-associated coding and non-coding genes in triple-negative breast cancer using an integrated omics approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.